Primary progressive aphasia
Primary progressive aphasia (PPA) is a type of neurodegenerative disorder that primarily affects language skills and communication. It is characterized by a gradual and progressive loss of language function, while other cognitive abilities may remain relatively preserved for at least 2 years after the onset of language symptoms.
Symptoms[edit | edit source]
The symptoms of PPA can vary depending on the specific type of aphasia. However, common symptoms include difficulty with speech, reading, writing, and understanding language. These difficulties can affect a person's ability to communicate effectively and can lead to frustration and social isolation.
Types[edit | edit source]
There are three main types of PPA: semantic variant PPA, nonfluent/agrammatic variant PPA, and logopenic variant PPA. Each type has distinct symptoms and is associated with different patterns of brain atrophy.
Causes[edit | edit source]
The exact cause of PPA is unknown, but it is thought to be related to the accumulation of abnormal proteins in the brain. These proteins can damage nerve cells in the areas of the brain that control language.
Diagnosis[edit | edit source]
Diagnosis of PPA is based on a detailed clinical evaluation, including a thorough medical history, neurological examination, and cognitive testing. Imaging studies such as MRI or PET scan may also be used to identify patterns of brain atrophy.
Treatment[edit | edit source]
There is currently no cure for PPA, but treatment can help manage symptoms. This may include speech and language therapy, medications to manage symptoms, and supportive care to help individuals and their families cope with the challenges of the disease.
Prognosis[edit | edit source]
The progression of PPA is typically slow, with language skills gradually declining over a period of years. However, the disease can eventually affect other cognitive abilities and lead to a more generalized form of dementia.
See also[edit | edit source]
Primary progressive aphasia Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD